Immunic, Inc. (IMUX) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Immunic, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.814 -- 00:00:04.577 Good morning and welcome to Munich's third quarter 2024 earnings call. 00:00:04.577 -- 00:00:09.060 My name is Jessica Bru, Vice President Investor Relations and Communications at the Munich. 00:00:09.060 -- 00:00:12.642 I will also be the moderator today. Speaking on the call are Dr. 00:00:12.642 -- 00:00:17.225 Daniel Fitt, our Chief Executive Officer, Glenn Whaley, our Chief Financial Officer, 00:00:17.225 -- 00:00:21.228 as well as Jason Tardio, our President and Chief Operating Officer. 00:00:21.228 -- 00:00:24.790 Please note that all participants will be in listen-only mode and this event is being 00:00:24.790 -- 00:00:26.286 recorded. 00:00:26.286 -- 00:00:30.389 After today's presentation, there will be an opportunity to ask questions. 00:00:30.389 -- 00:00:34.593 If you joined the webcast via the Zoom platform, there are two ways to submit questions. 00:00:34.593 -- 00:00:39.056 You can submit your questions in writing via the Q&A tool of the Zoom portal, or if you 00:00:39.056 -- 00:00:42.639 would like to speak with us directly, please use the raise hand function in the Zoom 00:00:42.639 -- 00:00:45.161 portal to queue your question. 00:00:45.161 -- 00:00:50.125 Before we begin, I would like to remind you that this presentation may contain forward-looking 00:00:50.125 -- 00:00:55.711 statements. Such statements can be identified by words such as may, will, expect, anticipate, 00:00:55.711 -- 00:00:58.014 estimate, or words with a similar meaning. 00:00:58.014 -- 00:01:02.541 And such statements involve a number of risks and uncertainties that could cause Immunix's 00:01:02.541 -- 00:01:06.767 actual results to differ materially from those discussed here. 00:01:06.767 -- 00:01:11.071 Please note that these forward-lookin...